Published in BMJ on August 10, 1996
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31
Semen quality in relation to biomarkers of pesticide exposure. Environ Health Perspect (2003) 1.94
Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol (2006) 1.93
The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids (2007) 1.46
Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis. Basic Clin Pharmacol Toxicol (2008) 1.36
Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis. Breast Cancer Res (2007) 1.35
Cancer risk in Swedish women: the relation to size at birth. Br J Cancer (2001) 1.01
Conditions in utero and cancer risk. Eur J Epidemiol (2006) 0.98
Estrogens and prostate cancer: etiology, mediators, prevention, and management. Endocrinol Metab Clin North Am (2011) 0.88
Childhood height and birth weight in relation to future prostate cancer risk: a cohort study based on the copenhagen school health records register. Cancer Epidemiol Biomarkers Prev (2013) 0.87
Birth size and colorectal cancer risk: a prospective population based study. Gut (2005) 0.87
An epidemiological study of cancer in adult twins born in Norway 1905-1945. Br J Cancer (2001) 0.85
Racial variation in umbilical cord blood leptin concentration in male babies. Cancer Epidemiol Biomarkers Prev (2011) 0.84
Birthweight, rapid growth, cancer, and longevity: a review. J Natl Med Assoc (2003) 0.82
Early-life estrogens and prostate cancer in an animal model. J Dev Orig Health Dis (2010) 0.81
Height-related risk factors for prostate cancer. Br J Cancer (2000) 0.80
Birth characteristics and risk of colorectal cancer: a study among Swedish twins. Br J Cancer (2009) 0.78
Gender-specific frequency of background somatic mutations at the hypoxanthine phosphoribosyltransferase locus in cord blood T lymphocytes from preterm newborns. Proc Natl Acad Sci U S A (1999) 0.77
Preeclampsia and adiponectin in cord blood. Horm Res Paediatr (2010) 0.76
Socioeconomic position in childhood and cancer in adulthood: a rapid-review. J Epidemiol Community Health (2015) 0.76
Baby Boomers and Birth Certificates: Early-Life Socioeconomic Status and Cancer Risk in Adulthood. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Influence of In Utero Maternal and Neonate Factors on Cord Blood Leukocyte Telomere Length: Clues to the Racial Disparity in Prostate Cancer? Prostate Cancer (2016) 0.75
Is birthweight associated with total and aggressive/lethal prostate cancer risks? A systematic review and meta-analysis. Br J Cancer (2016) 0.75
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell (1993) 13.54
Mutator phenotype may be required for multistage carcinogenesis. Cancer Res (1991) 7.29
Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer (1993) 6.24
A prospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 5.09
Cancer statistics, 1995. CA Cancer J Clin (1995) 4.73
Hypothesis: does breast cancer originate in utero? Lancet (1990) 4.22
Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst (1995) 3.67
Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics (1966) 3.60
A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst (1993) 3.40
The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol (1993) 2.95
Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res (1994) 2.89
High birthweight as a predictor of prostate cancer risk. Epidemiology (1995) 2.12
Rise in prostatic cancer incidence associated with increased use of transurethral resection. J Natl Cancer Inst (1990) 2.05
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77
The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer (1988) 1.66
Prostate cancer: a current perspective. Epidemiol Rev (1991) 1.61
Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst (1986) 1.54
Vasectomy and prostate cancer: results from a multiethnic case-control study. J Natl Cancer Inst (1995) 1.40
Studies in the epidemiology of prostatic cancer: expanded sampling. Cancer Treat Rep (1977) 1.34
Maternal age, parity, and pregnancy estrogens. Cancer Causes Control (1990) 1.32
Tobacco smoking, pregnancy estrogens, and birth weight. Epidemiology (1990) 1.31
Early life risk factors for prostate cancer: a population-based case-control study in Sweden. Cancer Epidemiol Biomarkers Prev (1995) 1.20
Is cancer causation simpler than we thought, but more intractable? Epidemiology (1995) 1.17
A prospective, population-based study of androstenedione, estrogens, and prostatic cancer. Cancer Res (1990) 1.14
Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men. Cancer Causes Control (1994) 1.10
Perinatal characteristics and adult mammographic patterns. Int J Cancer (1995) 1.04
Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst (1994) 0.99
Postatrophic hyperplasia of the prostate. A histologic mimic of prostatic adenocarcinoma. Am J Surg Pathol (1995) 0.96
Fetal growth and placental function assessed by urinary estriol excretion before the onset of pre-eclampsia. Am J Obstet Gynecol (1979) 0.89
Control of prostate growth. Urology (1981) 0.87
Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer--a population-based case-control study. Br J Cancer (1993) 0.87
Weight percentile at birth. II. Prediction by endocrinological and sonographic measurements. Eur J Obstet Gynecol Reprod Biol (1987) 0.86
Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate. J Steroid Biochem (1982) 0.86
High oestrogen excretion in pregnancy. Br J Obstet Gynaecol (1982) 0.85
New pathways in an age of ecological and ethical concerns. Int J Epidemiol (1994) 0.83
Serum levels of unconjugated and total oestrogens and dehydroepiandrosterone, progesterone and urinary oestriol excretion in pre-eclampsia. Gynecol Obstet Invest (1984) 0.82
Patterns of intrauterine growth retardation. Obstet Gynecol (1979) 0.81
Plasma steroid assay in the assessment of foetoplacental function. J Steroid Biochem (1975) 0.80
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med (1986) 11.17
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87
A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A (1991) 6.42
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med (1998) 5.66
Birthweight as a risk factor for breast cancer. Lancet (1996) 5.05
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand (1968) 4.82
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr (1995) 4.50
A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol (1999) 4.43
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
The clinical use of mindfulness meditation for the self-regulation of chronic pain. J Behav Med (1985) 4.08
Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Infections as a major preventable cause of human cancer. J Intern Med (2000) 3.96
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med (1996) 3.79
Coffee and cancer of the pancreas. N Engl J Med (1981) 3.79
The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77
Diet and overall survival in elderly people. BMJ (1995) 3.73
Stressful life events and Graves' disease. Lancet (1991) 3.63
Parity, age at first childbirth, and risk of ovarian cancer. Lancet (1994) 3.48
Should the mission of epidemiology include the eradication of poverty? Lancet (1998) 3.42
Exercise intensity and longevity in men. The Harvard Alumni Health Study. JAMA (1995) 3.41
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28
Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst (1993) 3.25
Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp Immunol (1970) 3.17
Lung cancer and passive smoking. Int J Cancer (1981) 3.14
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science (1994) 3.10
Lactation and cancer of the breast. A summary of an international study. Bull World Health Organ (1970) 3.04
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr (1999) 3.03
Lactation and reproductive histories of breast cancer patients in greater Athens, 1965-67. Int J Cancer (1969) 2.93
Coffee, pancreatic cancer and the question of causation. J Epidemiol Community Health (2000) 2.92
Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia (2006) 2.91
Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88
Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer (1990) 2.82
History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst (2000) 2.82
Green tea and the risk of gastric cancer in Japan. N Engl J Med (2001) 2.82
Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet (2000) 2.75
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
Drug surveillance utilizing nurse monitors. An epidemiological approach. Lancet (1966) 2.69
Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.69
Evidence for interaction between air pollution and high temperature in the causation of excess mortality. Arch Environ Health (1993) 2.67
Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.65
Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol (1981) 2.65
Risk factor patterns for cryptorchidism and hypospadias. Epidemiology (1999) 2.64
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet (1990) 2.58
Cigarette smoking and urinary estrogens. N Engl J Med (1982) 2.55
Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia (2007) 2.54
International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control (1997) 2.52
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology (1991) 2.51
Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51
Infant leukaemia after in utero exposure to radiation from Chernobyl. Nature (1996) 2.47
Slower heterosexual spread of HIV-2 than HIV-1. Lancet (1994) 2.46
Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece. J Natl Cancer Inst (1995) 2.44
Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol (1998) 2.38
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31
Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer (1989) 2.30
Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology (2001) 2.30
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29
Menopause and breast cancer risk. J Natl Cancer Inst (1972) 2.27
Fatty fish consumption and risk of prostate cancer. Lancet (2001) 2.27
The relationship between in vitro transformation and tumor formation in vivo. Biochim Biophys Acta (1976) 2.24
Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol Microbiol Scand A (1973) 2.23
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer (2007) 2.23